Clinical Trials

Text Size A A

E-Mail to a Friend

secret  Click to Play Audio

Bladder Cancer


Radiation Therapy + Chemotherapy for Stage T1 Bladder Cancer (UW 7684/RTOG 0926)
RTOG 0926 A Phase II Protocol For Patients With Stage T1 Bladder Cancer to Evaluate Selective Bladder Preserving Treatment By Radiation Therapy Concurrent With Radiosensitizing Chemotherapy Following a Thorough Transurethral Surgical Re-Staging.

Investigator: George Laramore, MD, PhD;   Conditions: Bladder Cancer;    Status: Recruiting;   Study ID: NCT00981656

Sirolimus + Cisplatin/Gemcitabine for Bladder Cancer (8027)
A Phase 1-2 Study of Rapamycin (Sirolimus) and Cisplatin/Gemcitabine for Treatment of Patients With Bladder Cancer

Investigator: Bruce Montgomery, MD;   Conditions: Bladder Cancer;    Status: Recruiting;   Study ID: NCT01938573

AGS15E for Metastatic Urothelial Cancer
A Phase 1 Study of the Safety and Pharmacokinetics of Escalating Doses of AGS15E Given as Monotherapy in Subjects With Metastatic Urothelial Cancer

Investigator: Evan Ya-Wen Yu, MD;   Conditions: Metastatic Urothelial Cancer;    Status: Recruiting;   Study ID: NCT01963052

Gabapentin for Bladder Cancer Patients Undergoing Surgery (9274)
Randomized placebo control trial of perioperative gabapentin to reduce total analgesic requirements in patients undergoing radical cystectomy

Investigator: Jonathan Wright;   Conditions: Bladder Cancer;    Status: Recruiting;   Study ID: NCT02355886